دورية أكاديمية
أعرض في EDS

The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives.

التفاصيل البيبلوغرافية
العنوان: The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives.
المؤلفون: Wisdom AJ; Harvard Radiation Oncology Program, Boston, Massachusetts., Barker CA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Chang JY; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Demaria S; Department of Radiation Oncology, Weill Cornell Medicine, New York, New York., Formenti S; Department of Radiation Oncology, Weill Cornell Medicine, New York, New York., Grassberger C; Department of Radiation Oncology, University of Washington, Fred Hutch Cancer Center, Seattle, Washington., Gregucci F; Department of Radiation Oncology, Weill Cornell Medicine, New York, New York., Hoppe BS; Department of Radiation Oncology, Mayo Clinic, Jacksonville, Florida., Kirsch DG; Department of Radiation Oncology, University of Toronto, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Marciscano AE; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Mayadev J; Department of Radiation Oncology, UC San Diego School of Medicine, San Diego, California., Mouw KW; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts., Palta M; Department of Radiation Oncology, Duke Cancer Center, Durham, North Carolina., Wu CC; Department of Radiation Oncology, Columbia University Irving Medical Center, New York, New York., Jabbour SK; Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. Electronic address: jabbousk@cinj.rutgers.edu., Schoenfeld JD; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address: Jonathan_Schoenfeld@dfci.harvard.edu.
المصدر: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2024 Apr 01; Vol. 118 (5), pp. 1404-1421. Date of Electronic Publication: 2024 Jan 05.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 7603616 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-355X (Electronic) Linking ISSN: 03603016 NLM ISO Abbreviation: Int J Radiat Oncol Biol Phys Subsets: MEDLINE
أسماء مطبوعة: Publication: New York, NY : Elsevier, Inc
Original Publication: Elmsford, N. Y., Pergamon Press.
مواضيع طبية MeSH: Neoplasms*/radiotherapy , Neoplasms*/drug therapy, Humans ; Immunotherapy ; Combined Modality Therapy
مستخلص: Immunotherapeutic agents have revolutionized cancer treatment over the past decade. However, most patients fail to respond to immunotherapy alone. A growing body of preclinical studies highlights the potential for synergy between radiation therapy and immunotherapy, but the outcomes of clinical studies have been mixed. This review summarizes the current state of immunotherapy and radiation combination therapy across cancers, highlighting existing challenges and promising areas for future investigation.
(Copyright © 2024 Elsevier Inc. All rights reserved.)
معلومات مُعتمدة: P30 CA008748 United States CA NCI NIH HHS
تواريخ الأحداث: Date Created: 20240106 Date Completed: 20240318 Latest Revision: 20240613
رمز التحديث: 20240613
DOI: 10.1016/j.ijrobp.2023.12.046
PMID: 38184173
قاعدة البيانات: MEDLINE
الوصف
تدمد:1879-355X
DOI:10.1016/j.ijrobp.2023.12.046